- University of Zurich
My group develops preclinical imaging techniques that link information on molecules, signaling pathways and cellular events to the changes that occur over time on the tissue and organ level in an integrative and quantitative way. We use magnetic resonance and optical imaging to combine the particular advantages of each methods with regard to its sensitivity and resolution. To this end, his group has pioneered a number of imaging technologies, including novel imaging contrasts, cell labelling strategies and reporter technology. Methods are employed in animal models of human diseases to study neurodegenerative, vascular and inflammatory pathways in the brain.
|Sep. 9 (Wed)
||(Short Talk) Tau Deposition Is Associated With Intracranial Calcification in the P301L Mouse Model of Human Tauopathy